linkedin Created with Sketch. twitter Created with Sketch. instagram Created with Sketch.
Shape
← Back to portfolio Porfolio / Cambridge Respiratory Innovations (CRI)

Cambridge Respiratory Innovations (CRI)

Transforming lives with disruptive respiratory technologies

Company overview

Cambridge Respiratory Innovations (CRI) creates ground-breaking respiratory technologies. In December 2020 it received funding from BGF and Downing Ventures to fast track research and development of its award-winning N-Tidal device to help medical professionals diagnose and monitor respiratory conditions. The N-Tidal device is a first-in-kind, connected, handheld capnometer incorporating unique patented sensor technology, that can accurately measure carbon dioxide levels in exhaled breath during normal breathing.

Company information

Head office
  • Cambridge
CEO
  • Dr James Whitticase
BGF office
Investment date
  • Dec 2020